American Society for Bone and Mineral Research

Among a cohort of postmenopausal women randomly assigned to romosozumab or alendronate, larger improvements in bone mineral density and bone strength in the lumbar spine were observed for those taking romosozumab, according to findings presented at the American Society of Bone and Mineral Research annual meeting.

Bone mineral content and density improved following a resistance training program included with school-based physical education for middle school girls, and these results largely held in subsequent years, according to findings presented at the American Society of Bone and Mineral Research annual meeting.

Daily vitamin D supplementation does not influence the progression of arterial calcification or increase the likelihood that the condition will develop, according to findings presented at the American Society of Bone and Mineral Research annual meeting.

Postmenopausal women who took denosumab for a year did experienced no significant decrease in bone mineral density after switching to alendronate, according to findings presented at the American Society of Bone and Mineral Research annual meeting.

Debate continues among endocrinologists regarding what constitutes the “optimal” level of vitamin D, and dozens of studies have assessed the benefits of vitamin D supplementation on everything from fracture risk to diabetes and autoimmune disease. Most recently, the large-scale VITAL trial, presented in November at the American Heart Association Scientific Sessions, suggested the supplement failed to prevent major cardiovascular events and the development of invasive cancers over 5 years, although a deeper dive into the findings reveals a signal for benefits with vitamin D for certain subsets of patients.

Older women randomly assigned a daily 1.2 g calcium supplement for 5 years were no more likely to develop abdominal aortic calcification vs. similar women assigned placebo, according to study data presented at the American Society for Bone and Mineral Research annual meeting.

Approximately 11% of middle-aged adults in the United States have osteoporosis, with the cost for care rising by nearly $50 billion over more than a decade, according to study data presented at the American Society for Bone and Mineral Research annual meeting.